Oxygen Tension: Direct Observations on the Critical Level for the Brain by Jӧbsis, Frans F.
Oxygen Tension: Direct Observations 
on the Critical Level for the Brain*t 
FRANS F. JOBSIS 
Department of Physiology and Pharmacology, Duke University 
School of Medicine, Durham, North Carolina 27706 
In this lecture I want to address 
myself to the questions: What is the 
lowest oxygen tension compatible 
with adequate function, and what 
are the factors that set this limit? 
Much of the background to the 
material presented here has been 
reviewed extensively in the not too 
distant past (JObsis '64), and I 
will take the liberty of letting that 
article provide most of the detailed 
justification of my remarks today. 
I. Mechanisms of Oxygen 
Utilization 
In mammals there are three 
mechanisms for the utilization of 
dissolved oxygen. First, I will list 
these, and then I will emphasize the 
last one of these, since it accounts 
for the major part, by far, of the 
oxygen uptake in the body. These 
three are: 
A. Oxygen trans/erases 
for which the generalized re-
action can be written 
A+ 0 2 ~ A02 
in which A is a substrate that 
accepts two separate oxygen atoms; 
B. Mixed function oxidases 
with the reaction 
AH+ 2e- + o.~ AOH + o= 
(~H20) 
where the last notation signi-
fies the rapid final step of water 
production from o= and 2H+ ions; 
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C. Electron transfer oxidases 
catalyzing the reaction 
4e- + 02 ~20= (~2H,O) 
Numbers one and two are mainly 
active in the catalytic oxidation of 
amino acids and of some steroids 
and account at most for 1 % of 
the total 02 consumption in mam-
mals. They are, therefore, of very 
little importance to us in this 
symposium. 
The enzyme systems catalyzing 
the last category can be subdivided 
into, firstly, autoxidative flavopro-
teins and, secondly, the respiratory 
chain. 
1. The oxidation of autoxida-
tive flavoproteins can be written 
flavinH, + 0 2 ~ flavin + H.O. 
The hydrogen peroxide formed is 
removed by the action of catalase. 
These reactions may account for 
about 10% of the total oxygen up-
take in the body. We are not too 
sure where this uptake takes place 
or even what subdivision of the cell 
is the site of this oxygen consump-
tion. One of the few known vari-
ables affecting this reaction is ac-
climation. Russian workers have 
shown that, during hibernation, 
the fraction mediated by the autox-
idative flavoproteins goes from 
10% to approximately 25% (Sku-
lachev, 1962). Another important 
fact is that no mechanism has been 
found by which energy conserva-
tion takes place in this reaction. 
More specifically, no high energy 
phosphate production has been 
found associated with this reaction. 
2. The respiratory chain ac-
counts for all the rest of the oxygen 
taken up by the tissues. This is the 
mitochondrial contribution to over-
all oxidative metabolism. A system 
of redox couples catalyzes the trans-
fer of reducing equivalents from the 
substrates to oxygen and results in 
the formation of water. This is 
shown in Figure 1 together with 
some of the inhibitors and side 
reactions of the respiratory chain. 
In the respiratory chain three lo-
cations, identified by asterisks in 
the above scheme, contribute to the 
overall process by being loci for 
the conservation of energy in the 
form of high-energy phosphate 
bonds (-P) that are transferred to 
adenosine diphosphate (ADP) to 
form adenosine triphosphate 
(ATP). The reaction, which is re-
ferred to as oxidative phosphoryla-
tion, is obligatorily coupled to the 
electron transfer steps in the chain. 
This coupling produces an effective 
control mechanism for the rate of 
oxygen uptake. If no ADP is avail-
able, no oxidative phosphorylation 
can take place, and electron trans-
port is slowed down dramatically. 
This gives rise to the difference in 
rates of O, consumption during 
rest and during strenuous exercise. 
Failure of oxidative phosphoryla-
tion to take place is the main harm 
associated with anoxia. The respira-
tory chain plus its side reaction, 
oxidative phosphorylation, is, there-
fore, the reaction system that must 
be understood for any discussion 
of critical O, levels. I would like to 
discuss these processes now. 
Starting at the substrate side of 
the respiratory chain, we enter 
with certain substrates and their 
dehydrogenases which will reduce 
NAD+ to form NADH (nicotina-
mide-adenine di nucleotide). [The 
old-fashioned name was DNP, and 
many people still refer to it as 
DPN+ and DPNH]. NADH is able 
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to reduce flavoproteins and, then, 
from there, follow a set of redox 
couples, each one oxidizing its pred-
ecessor by electron transfer and be-
ing oxidized by the next one until O, 
is reached. This is a set of cyto-
chromes identified by letters, i.e., 
cytochrome b, cytochrome c,, cyto-
chrome c, cytochrome a and cyto-
chrome a,. Potential differences be-
tween the numbers of the respira-
tory chain are neatly arranged along 
the line so that electron transfer 
proceeds naturally toward o •. 
At three locations, the potential 
energy of the overall reaction-
which in the end is really the re-
action of hydrogen in the substrate 
with oxygen to form H.O- this 
potential energy of burning up the 
substrate is saved. In these three 
spots, reactions take place resulting 
in the formation of ATP from ADP 
and inorganic phosphate. There are 
three of these sites, and three P 
moieties are formed per oxygen 
atom. However, there are certain 
substrates, such as succinate, that 
are oxidized without benefit of 
NAD, and their oxidation only 
yields 2,_, P, since the site between 
NAD and flavoprotein is Jost. 
These two functions, electron 
transfer and high energy phosphate 
production, are very tightly coupled. 
They are obligatorily linked. With-
out the one the other does not take 
ma late 
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place, unless something is amiss. 
This brings with it some very im-
portant corollaries. For instance, 
if there is not enough ADP near the 
mitochondria, oxygen uptake comes 
to a halt, because partial blocks 
occur at three steps. This is referred 
to as respiratory control. In the 
same vein, the absence of electron 
acceptor (02) results in stoppage of 
electron transfer and, therefore, no 
further oxidative phosphorylation 
takes place. This is the fatal out-
come of asphyxiation. 
II. Main Phases of Foodstuff 
Degradation 
After this very rapid introduc-
tion, I would like to discuss some of 
these points more quantitatively 
and emphasize the methods that 
are available for the study of the 
respiratory chain. I think this is 
very important, and I am glad that 
Professor Patterson emphasized 
your interest in methods. Without 
an understanding of the methods, 
we really don't have a thorough 
understanding of the reliability of 
a scientific assertion, especially at 
the level of complexity that we 
meet in biology. Therefore, I will 
emphasize the methods as we go 
along. 
Starting then on the substrate 
side, Table 1 summarizes the re-
actions between the ingestion of 
food and the form in which it 
enters the Krebs cycle. The table is 
adapted from Krebs and Kornberg 
(1957) and speaks further for it-
self. What occurs is a rather amaz-
ing simplification of a great variety 
of compounds. The cell modifies 
and simplifies these complex sub-
stances into a rather small number 
of intermediates. Thus, we end up 
with acetyl coenzyme A and a few 
other things such as a-ketoglutaryl 
and oxaloacetic acid. In the third 
phase these three feed into the citric 
acid cycle, and there decarboxyla-
tion and dehydrogenation take 
place. This, of course, is the im-
portant step; this is where NADH 
is being formed. I always like to 
think of decarboxylation as just 
getting rid of the carbons. No ener-
getically advantageous steps are in-
volved in it. The carbons can be 
looked upon as nothing more than 
vehicles for carrying hydrogens 
around the citric acid cycle for the 
reduction of NAD and fiavopro-
teins. 
In Table 2 I have taken these 
same four phases and emphasized 
the high energy yield per carbon 
atom. It is very straightforward for 
carbohydrates: 6.4,_, P per carbon. 
It is a bit arbitrary for fats, be-
cause they differ so much in chain 
length. I have chosen palmitate as 
Electron transfer inhibitors NADH (2)~~', ~ Antimycin A / ~0 ',~,~ urethane c N 
,/ l3), BAL s= 
( "'~', HOQNO N3 
etc. * I '~ ' * * I 
a-ketogiutarate 
p-OH butyrate 
Glutamate 
Substrates ~NADH ~ fp ~ cyt.b r=:::= cyt .c 1~ cyt.c ;.::==:: cyt.a ;.::==:: cyt .a~o, 
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a-glycerophosphate ~/ 
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Fig. 1-The respiratory chain. The asterisks indicate the probable locations of the phosphorylative steps. The dashed lines 
illustrate the point of action of inhibitors blocking the transfer of electrons to oxygen. (BAL: British Anti-Lewisite; HOQNO: 
a-hydroxy quinoline N-oxime.) (Reprinted with permission from Handbook of Physiology, Ji:ibsis, 1964.) 
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TABLE 1 
The four main phases of foodstuff degradation 
Phase Outline of Chemical Change I Primary Reactions 
- · 
I carbohydrates proteins fats depolymerization 
l l l 
hexoses about 20 amino acids glycerol; fatty acids 
-
II hexoses glycerol several fatty several several several dehydrogenation, 
l amino acids acids amino acids amino acids amino acids decarboxylation, 
lactic (alanine, j 6 "~"·~. (glutamic (aspartic acid; deamination and acid serine, tyrosine, acid, tyrosine, shortening of the 
I cysteine) phenyl- histidine, phenylalanine) carbon chain I alanine) prolines, 
1 _J arginine) pyruvic acid l 
l a-ketoglu- oxaloacetic taric acid ' acid 
acetyl coenzyme A 
III acetyl coenzyme A a-ketoglutaric acid oxaloacetic acid decarboxylation 
L I J and 
l dehydrogenation 
citric acid .cycle 
~· 
l l 
IV NADH flavin-H2 H20 production 
L I 
respiratory chain 
TABLE 2 
Location, products and profits of the four main phases of foodstuff degradation 
Reducing Equivalents ~P Yield Per Carbon Atom 
Phase Primary Location Waste Chemical Change Products 
Yield Destination CarOO- Fats hydrates 
I-
I D epolymerization Extracellular and None None None None 
cytoplasmic 
---
II D ehydrogenation, Cytoplasmic and NH3 and urea; Small amounts of Used in 0. 33 - o.o6 
decarboxylation , intramitochon- small amounts of NADH and IV 
deamination, and d r ia l C O , and H ,O flavin-H2 
shortening of the 
carbon chain 
III Decarboxylation Intra- co, Large increase in Used in 0.33 0 .50 
and dehydro- mitochondrial NADH and IV 
genation fluid pha se flavin-H2; small 
increase in 
NADPH 
IV H20 production Mitochondria l H20 Large decrease in 5 .7o 8.oo 
membra nes NADH and 
I flavin-H2 
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an example. The longer the chain, 
the higher your net yield, since you 
have to pay a standard price in acti-
vation no matter how long the 
chain. I have not even attempted 
to calculate a similar number for 
amino acids; they are too dissimilar. 
Note that, in the first stage, there 
is no yield of high energy phos-
phates. In the second stage there is 
a very small yield, and actually there 
is utilization of high energy phos-
phates in fatty acid metabolism. 
There is an extremely small pro-
vision by so-called substrate level 
phosphorylations in the third phase, 
the citric acid cycle level. In the 
fourth or final phase, however, the 
great bulk of high energy phos-
phates arises. In other words, the 
most important yield derives from 
the last phase, and it is mediated by 
the respiratory chain. 
It is simple enough to measure 
these reactions in a vessel, a mano-
metric one if you need to know the 
amount 0, consumed. It is more 
meaningful, however, to study the 
system in the intact, circulated tis-
sue rather than with slices or iso-
= 
Tun9sten or· f:\ hi9h pressure 
\J HQ arc lamp 
Synchronized Chart 
with linear wovelenoth scale 
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lated mitochondria. It is here that 
special instrumental methods are 
needed. Almost without exception 
such methods have been pioneered 
since 1946 by Dr. Britton Chance 
at the Johnson Foundation, Depart-
ments of Biophysics and Physical 
Biochemistry of the University of 
Pennsylvania. 
Ill. Split-Beam 
Spectrophotometric Method 
The great boon in the study of 
the respiratory chain, and actually 
the factor upon which the dis-
covery of the cytochromes hinged, 
is the fact that each of the mem-
bers has optical activity: they ab-
sorb light at specific wavelengths. 
In the 1920's, Professor Keilin first 
described the series of components 
that is now known as the cyto-
chrome chain (Keilin, 1925). Al-
though he drew some strong in-
ferences regarding its function, he 
did not know, at that time, that 
energy was being conserved in con-
junction with the cytochrome ac-
tivity. That had to wait until the 
Optical Density 
Fig. 2-The split-beam, difference spectrophotometer. The difference in light 
intensity emerging from the two sample cells is logarithmically recorded on a 
chart directly coupled with the wavelength drive of the monochromator. The 
resulting graph is a recording of the difference in optical density at the various 
wavelengths. (Reprinted with permission from M ethods in Enzymology, 
Chance, 1957.) 
172 
late 1930's. All of his conclusions 
were the result of visual spectros-
copy. Nowadays we use spectro-
photometry to do the same thing. 
In this approach one first needs to 
determine the identity and the con-
centration of different components. 
For this purpose a special type of 
spectrophotometer, the so-called 
"split-beam," is used. It is especially 
designed for highly light-scattering 
preparations such as mitochondria 
suspended in a solution or intact 
tissue. The instrument is shown in 
Figure 2. Starting from the light 
source, the beam is diffracted in a 
monochromator and is alternately 
deflected by means of an oscillat-
ing mirror through two cuvettes 
placed side by side. One of these is 
the sample; the other serves as the 
reference. The light emerging from 
these two cuvettes is measured by 
a photomultiplier. There is a bit 
of electronic circuitry concerned 
with unscrambling the pulses so 
that one can keep track of the light 
absorption of the sample as com-
pared with the reference cell. After 
subtraction, the difference is re-
corded logarithmically. This ren-
ders the data directly in OD units 
which are proportional to concen-
trations. The monochromator 
sweeps through the wavelengths 
from about 650 m,u, which is the 
dark red, to about 300 mµ. in the 
very near UV. The differences in 
absorption are recorded on a wave-
length scale. Starting with two sus-
pensions of isolated mitochondria, 
for example, the first run provides a 
base line, since one started out with 
equal samples. After an experi-
mental manipulation, for instance 
the removal of oxygen, one sweeps 
through again, and the difference 
between the oxidized and the re-
duced materials is now recorded. 
Figure 3 shows two absolute spec-
tra and their difference spectrum, 
using hemoglobin as an example. 
The absorption spectrum of hemo-
globin in the oxygenated form is 
shown by the solid curve, in the 
disoxygenated form by the broken 
curve. These are absolute spectra; 
but if one puts a disoxygenated sam-
ple of hemoglobin in the sample 
cuvette and oxygenated hemoglobin 
in the reference cuvette, the result-
ing curve is a difference spectrum, 
as shown in the upper part of Fig-
ure 3. 
Studies on Mitochondria 
The same thing can be done for 
the respiratory chain in the mito-
chondria. Mitochondria are ob-
tained from the cells by grinding 
and differential centrifugation. They 
are suspended in an appropriate 
medium and aliquots are pipetted 
into the two cuvettes. The spectrum 
in the top of Figure 4 shows the 
differences in OD between oxy-
genated and anoxic mitochondria. 
The latter were on the sample side; 
the former served as reference. The 
location of the peaks identifies the 
components; the height of the peaks, 
the concentration. Reduced cyto-
chromes and NADH have absorp-
tion bands that are sharper and 
more intense than those of the 
oxidized form. Therefore, the peaks 
are in the upward direction. The 
cytochromes produce a complex of 
beta bands which are rather inde-
finable and are grouped together. 
Note that the large trough at 465 
mµ. is related to flavoprotein re-
duction; in contrast with the cyto-
chromes, the flavoproteins absorb 
more strongly in the oxidized form. 
Studies on Muscle 
Since I am a physiologist, I con-
sider it important to show that this 
is not a biochemist's artifact; that 
it is possible to measure the cyto-
chrome absorption peaks in whole 
cells also. One does this by taking 
two pieces of tissue, for instance, 
two muscles carefully dissected, one 
from the left leg and one from the 
right leg, and measuring the dif-
ference spectrum between the 
anoxic sample and the oxygenated 
reference. The result is the lower 
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spectrum of Figure 4. With some 
minor differences it is much the 
same as the spectrum of the iso-
lated mitochondria. So it is possible 
to make these observations and 
measure the concentrations in in-
tact tissues. For a physiologist that 
is reality. Now we can use the 
level of reduction as an indicator 
system. For Professor Keilin it was 
the beginning. After his visual ob-
servations of the cytochrome bands 
in intact cells, he was obliged to 
isolate and identify the compounds 
giving rise to them. Some thirty 
years later Dr. Chance was able to 
quantitate the observation in tis-
sues with his new instrumentation. 
Nowadays it is not too difficult to 
make identifications and measure 
concentrations in most any tissue 
that interests you. 
Reduction Level of Metabolic 
States 
Since we now have a method 
for following changes in oxidation 
and reduction of the members 
of the respiratory chain, the ques-
I I I I I I I I I I I I I I I I I I I I I I I I I I 
400 4SO 410 490 1120 11110 lie() t10 140 
' 
' I 
! 
I 
I\ 
I I 
I I 
! ~ 
' I 
' ' 
I 
' I 
I 
:r \400.1 o.~ 
jlljlljiijlljlljlljiiji jlljl 
370 400 430 460 4°!10 520 550 510 610 640 
'111111) 
Fig. 3-Absolute spectra of oxygenated (solid line, bottom) and disoxygenated 
hemoglobin (broken line) and their difference spectrum (top). 
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tion of their reduction level in 
different metabolic states can be 
tackled. Not that we are so very in-
terested in the cytochromes per se, 
but they serve as indicators of 
changes in the rate of oxygen up-
take. For example, 0 2 uptake will 
be slow when ADP is lacking in a 
suspension of mitochondria other-
wise supplied with all the needs for 
oxidative phosphorylation (i.e., 0 2, 
inorganic phosphate and oxidizable 
substrates) . Addition of ADP will 
then produce a rapid uptake of 
oxygen, which will slow down again 
when all the ADP has been turned 
into ATP. This can be followed 
very easily with an oxygen polaro-
graph, an "oxygen electrode." This 
is the ideal experiment for deter-
mining what happens to the reduc-
tion states of the members of the 
respiratory chain when oxidative 
metabolism changes, as I will show 
in just one minute. Concomitantly 
with the O., substrate, ADP and 
inorganic phosphate will disappear. 
A measure of the efficiency of phos-
phorylation is the well-known P to 
0 ratio, i.e., the ratio of the amount 
of inorganic phosphate that disap-
pears to the number of oxygen 
atoms utilized. For an NADH-
linked substrate it is 3; for a flavo-
protein substrate it is 2; when the 
entire Krebs cycle is operating, we 
get an intermediate value, say, 2.5 
to 2.7. 
Such measurements are possible 
with mitochondria in a cuvette, but 
not in intact cells. What is possible, 
however, is the monitoring of the 
optical density changes related to 
reduction level changes of the cyto-
chromes. These absorption effects 
were first measured in isolated 
mitochondria and were found to 
be very specific as we do the ADP 
addition experiment. For this we 
use a slightly different spectro-
photometer. The first one I de-
scribed can only be used for steady 
states when we are identifying 
components or looking for con-
centrations. Now we need to follow 
changes in absorption over a limited 
time span. 
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IV. Double-Beam 
Spectrophotometric Method 
For this purpose Dr. Chance de-
veloped the so-called "double-beam" 
spectrophotometer (Fig. 5). A sin-
gle light source is used for two 
monochromators. One is set for the 
wavelength of an absorption peak, 
the other at an indifferent wave-
length to serve as a reference beam. 
The two beams are alternately 
switched by a vibrating mirror, pro-
ceed through the sample, and the 
emerging light is measured by an 
end-window photomultiplier. This 
340 370 400 430 460 
NAOH o3(•o)y 
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0 
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0 .00 
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system is needed, because the sus-
pensions (and the tissues as well) 
are turbid. What is more, the light 
scattering is greatly affected by all 
sorts of metabolic reactions. When 
light-scattering changes take place, 
they are indistinguishable from ab-
sorption changes. Both result in 
changes in photomultiplier current, 
because light is lost. However, it is 
lost equally, at first approximation, 
from the reference and measuring 
wavelengths. Therefore, changes in 
the difference between the two 
beams are significant, not the total 
signal. Total signal changes 20 
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Fig. 4-Difference spectra of the respiratory chain. Sample: reduced by anoxia; 
reference: in the presence of oxygen. Upper curve: two aliquots of suspended 
mitochondria isolated from rat liver [anoxic (state 5) minus starved (state 2)]. 
Lower curve: two excised toad sartorius muscles [anoxic (state 5) minus resting 
with endogenous substrates (state 1)]. (Reprinted with permission from Hand-
book of Physiology and J. Gen. Physiol., JObsis, 1963 and 1964.) 
times greater than the true absorp-
tion changes can thus be tolerated. 
Studies on Mitochondria 
If we follow the absorption of 
one of these cytochromes as we go 
through some of the more obvious 
metabolic conditions, we will see a 
characteristic pattern emerge (Fig. 
6). At 430 - 400 m,u, cytochrome 
b is monitored. As the mitochondria 
come out of the c~ntrifuge tube and 
are put in a cuvette, we start the 
trace. Now we add ADP, and a de-
creasing absorption at 430 m,u com-
pared to 400 m,u, signifies that an 
oxidation of cytochrome b takes 
place. This is inevitable. Substrates 
have not been added . The ADP-
stimulated, high rate of 0 2 uptake 
soon exhausts the endogenous sub-
strate supply of the mitochondria, 
and cytochrome b goes fully oxi-
dized. At this point .,B-hydroxy-
butyrate is added, NAD is reduced: 
we see a change towards a higher 
level of reduction. A plateau is 
maintained for a short while; then 
another change occurs. Concom-
itant biochemical determinations 
will show that at this point the ADP 
that was added has now been phos-
phorylated to ATP. Electron trans-
fer slows down, and a more re-
duced state results because of the 
blocking of the respiratory chain 
further down, close to oxygen. Re-
ducing equivalents accumulate, 
therefore, in cytochrome b. When 
oxygen uptake is stimulated again 
by a new addition of ADP, cyto-
chrome b returns to the previous, 
more oxidized state while ATP is 
being formed. After a number of 
such cycles, all the oxygen is used 
up, and an extremely large change 
will indicate that b goes completely 
reduced. Very much the same thing 
occurs for NADH, as is shown in 
the right-hand record of Figure 6. 
These steady-state changes are 
the important ones for our attempts 
to measure metabolic rates in the 
whole cell- especially this last 
transition to full reduction when the 
PO. is inadequate. It provides the 
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Fig. 5-The double-beam, difference spectrophotometer. The difference in light 
absorption of two beams of different wavelengths are recorded as a function of 
time. The resulting graph shows the kinetics of the wavelength-specific absorp-
tion changes; for instance, after the addition of a reactant. (Reprinted with per-
mission from M ethods in Enzymology, Chance, 1957.) 
430-400m11 l. 
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Fig. 6- 0xidation-reduction levels of cytochrome b and NADH1 in suspensions: 
of rat liver mitochondria in states 1 to 4. Note the reduction that occurs after 
addition of NAD-dependent substrate (tJ-hydroxybutyrate) and the return from 
the state - 4 to the state - 3 level upon the last ADP addition. (Reprinted with 
permission from Handbook of Physiology, JObsis, 1964, adapted from /. Biol. 
Chem. , Chance and Williams, 1955.) 
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signal to determine the critical level 
of oxygen needed for the cell. In 
Table 3 the metabolic states are 
listed as they were defined in the 
original article of Chance and Wil-
liams in 1955. The numbers of the 
states correspond to those along the 
traces in Figure 6. 
Studies on Muscle 
Showing again my bias as a 
physiologist, I do want to empha-
size that these changes do not only 
occur in mitochondria in a cuvette, 
but can also be seen in muscles. 
The same double-beam system can 
be used. Light of two wavelengths 
shines alternately through a muscle 
in the resting metabolic state. This 
provides the base line for the ex-
periment (Fig. 7). A number of 
rapid twitches are induced, ATP is 
hydrolyzed to ADP and recovery 
metabolism starts. All the optical 
changes of Figure 7 are in complete 
accord with the notion that we are 
observing the switch to rapid me-
tabolism (state 4 to state 3). When 
the ATP has been rephosphory-
lated, metabolism slows down and 
the optical density returns to that 
of the resting state. NADH and 
cytochrome b went through a cycle 
of increased oxidation; cytochrome 
c went more reduced. The dif-
ference between c in the muscle and 
the effect listed in Table 3 is not sig-
nificant. Since 1955 it has been 
shown that c can be more reduced 
TABLE 3 
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in state 3 than in state 4. It de-
pends on the tissue from which the 
mitochondria were prepared and 
on the type of substrate furnished. 
The important conclusion is that 
steady-state changes in the respira-
tory chain components can be 
demonstrated in intact tissues when 
the rate of o. consumption changes. 
V. Fluorometric Method 
Studies on Toad Sartorius Muscle 
In addition to spectrophotometry, 
fluorometric observation of NADH 
is also possible and has great ad-
vantages, especially in tissues with 
intact blood supply. This method 
rests on the fact that reduced NAD 
fluoresces when illuminated with 
light near its absorption peak at 340 
mµ,. It then emits light with a broad 
maximum at about 450 mµ,: a 
bluish cast comes from the tissue. 
Not all of it is derived from 
NADH, but a large part is. Since 
the oxidized form (NAD+) does 
not fluoresce, we now have another 
optical measure of the reduction 
state of NAD. 
This method is actually simpler. 
The intensity of the fluorescent light 
is measured with a photomultiplier. 
The same surface that is exposed to 
the excitation light (usually the 
366 mµ, line of a high pressure 
mercury arc) is used for observa-
tion. An appropriate secondary 
filter between the photomultiplier 
and the tissue screens out the re-
flected 366 mp. light. In addition to 
being simpler, the method is also 
more sensitive than the spectro-
photometric one. This is shown in 
Figure 1, which shows the response 
to a single twitch. Note that the 
spectrophotometric cycles of Figure 
8 were the responses to 30 twitches. 
Since this figure was published, 
further improvements have been 
made, so that now a response of the 
size shown in Figure 8 shows prac-
tically no noise. I have actually 
performed experiments with a re-
producibility within 2% for a 
dozen single twitches over a period 
of three or four hours. 
Studies on Tissue In Vivo 
However, we need to know about 
the whole tissue, the intact tissue in 
vivo. Excised tissue is only one step 
in that direction. Now that there is 
a method available for looking at 
the surface of tissues and saying 
something about the reduction of 
NAD, we can apply it to tissues 
with intact circulation. For observa-
tion we can use any exposed tissue, 
in our case, most significantly, the 
cerebral cortex. The apparatus is 
relatively simple. A microscope 
with an epi-illumination system 
looks down on the cerebral cortex. 
Light from an arc lamp is made to 
emerge as a cone around the ob-
jective of the microscope and is 
Metabolic states of mitochondria and associated oxidation-reduction levels of respiratory enzymes 
Characteristics Steady-State Percentage Reduction of Components 
J 
State [0.l ADP Substrate Respiration Rate-limitfug a c b Flavo- NADH1 level level rate substance protein• 
------
1 >o Low Low Slow ADP 0 7 17 21 ~go 
2 >o High ~o Slow Substrate 0 0 0 0 0 
3 >o High High Fast Respiratory 4 6 16 20 53 
chain 
4 >o Low High Slow ADP 0 1_4 35 40 99 
5 0 High High 0 Oxygen ~100 ~100 ~100 l"":"-'100 ~100 
These values are based on the amount of flavoprotein of the respiratory chain. Other fractions, reduced by anoxia, are 
present but disregarded here. [After Chance & Williams] 
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focussed on the observed spot. 
Emitted fluorescence, as well as re-
flected excitation light, enters the 
objective lens and goes up the. tube. 
The latter is filtered out so that only 
the fluorescence light remains. 
Much of it, but certainly not all, is 
that derived from NADH. A photo-
multiplier measures the light in-
tensity at the level of the ocular. 
Minimal 0 , Requirement of the 
Brain 
This instrumentation enables us 
to evaluate the minimal 02 require-
ments of the brain. The first type 
of experiment to do is the adminis-
tration to the animal of gas mixtures 
low in 0 2. The type of effect we 
look for is an increase in fluores-
cence, signalling that in some parts 
of the tissue the respiratory chain 
is not furnished with 0 2 and NAD• 
goes to NADH. Such an experiment 
on the kidney and brain of the rat 
is shown in Figure 9. The animal 
is switched from air to 100% N2 
or to 3% 02 in N2 • This results in 
a rise in the fluorescence, indicated 
by the downward excursion of the 
trace in Figure 9. I apologize sin-
cerely for the change in direction. 
Dr. Chance and I have always been 
opposed in our views about how to 
display this, so I am afraid you will 
have to switch back and forth 
between the experiments that we 
did together and the ones that I did 
myself. In his case, an increase in 
fluorescence is downward, and in 
my case an increase in fluores-
cence is upward. 
As expected, an increase in flu-
orescence accompanies anoxia. Ad-
dition of sulfide also increases flu-
orescence since it blocks the chain at 
the level of cytochrome a,.. All other 
components of the chain, including 
NAD, become reduced. The same 
thing can be shown for cyanide and 
CO; they all block at the level of a,. 
Amytal will also produce increased 
fluorescence by blocking the chain, 
this time, however, by inhibiting 
the flavoproteins oxidizing NADH. 
These maneuvers with anoxia (or 
F. F. JbBSIS 
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30 twitches in 10 seconds 
340-374 mµ Log lo/I :0.()()2 
DPNH oxidized f 
430-410mµ Loglo/'1=0002 I 
cytochrome b oxidized f 
419·405 mµ Log Iojl=0.002 
-cytochrome c redUced J, = 
Fig. 7-Steady-state changes of DPNH (NADH), cytochrome b and cytochrome 
c in toad sartorius muscles during oxidative recovery from contractile activity. 
The vertical ordinates are one minute apart. (Reprinted with permission from 
J. Gen. Physiol., JObsis, 1963.) 
hypoxia) and various inhibitors 
show that the instrumentation does 
perform in the intact tissue as 
hoped for. 
Limiting Factors in 0 , Uptake 
Now we should stop for a 
moment and reflect on the exact 
question of the day. We are ask-
ing: What are the parameters that 
determine the level of 0 2 neces-
sary for the tissue? It has been my 
experience that most of us tend to 
look immediately toward the pa-
rameters of circulation, the source 
of the 0 2, such as hemoglobin, PO,, 
blood flow, A-V differences, etc. 
However, although terribly rele-
vant, there is a more basic aspect. 
That is the question: What limits 
the rate of 0 2 uptake when P02 
does not? 
i FLUORESCENCEl 
--+---+---DECREASE 
2% 
I TOAD SARTORIUS 
i _ ~ 11.7 °C T.C. 5.5 aec. 
Fig. 8-Fluorescence cycle induced by an isometric twitch. Toad sartorius mus-
cle. A decrease in NADH concentration would be registered in a downward 
direction. (Reprinted with permission from J. Gen. Physiol., JObsis and Duffield, 
1967.) 
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Studies on Cells 
First we should discuss what hap-
pens in intact cells. We can meas-
ure the rate of oxygen uptake as 
a function of the partial pressure of 
oxygen in the cuvette. Diffusion 
problems from the blood vessels to 
the cells are sidestepped. In Figure 
10 we see such an experiment for 
yeast cells. The same thing has been 
done wi th other cells. It is im-
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portant to obtain a good measure-
ment of the P02 at which the rate 
of oxygen uptake is decreased. It is 
immediately obvious from the two 
sets of experiments that the pres-
ence of glucose makes an enormous 
difference on both the rate of oxy-
gen uptake and the P02 at which the 
plateau rate starts to fall. The im-
portant point is that in the absence 
of glucose, the availability of sub-
strate was the limiting factor long 
Rot Brain 
Rot Kidney 
100% -+- 30/o 100•1.----f 
~2min~ 
!--Manual Ventilotion--oj 
A 
\--- 2min---<\ 
B 
Fig. 9- Fluorescence changes induced by anoxia or severe hypoxia and by sul-
fide (an electron flow inhibitor) in the kidney and brain of rats. The top line 
shows the periods during which different gases were respired. An increase in 
NADH concentration would be registered in a downward direction. (Reprinted 
with permission from Science, Chance et al. , 1962.) 
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Fig. 10-The rate of oxygen consumption of yeast cells in succinate buffer as a 
function of P02. Top curve: glucose added as substrate. (Reprinted with permis-
sion from Handbook of Physiology, JObsis, 1964, adapted from J. Cellular 
Com. Physiol., Winzler, 1941.) 
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before the P02. Succinate, although 
metabolized rapidly, penetrates 
slowly and thus provides only in-
adequate substrate levels in the 
cells. Those experiments were, 
therefore, run in a semi-starved 
condition. The PO, at which the 
two systems begin to show signs 
of being limited by o. availability 
are 2.5 and 0.21 mm Hg. This ten-
fold difference is the result of the 
difference in rate of metabolism 
due to substrate limitations. When 
you ask me what the limiting level 
of 0 2 is, I will have to ask you, 
first, what the rate of respiration is 
in terms of total capacity and, then, 
what is limiting the rate? Because it 
could also quite well be that the 
limit is not the substrate but the 
blocks accompanying a decreased 
demand for oxidative phosphoryla-
tion .. The effects of these two causes 
of a less than maximal rate will be 
slightly different, but, for the mo-
ment, that is of secondary impor-
tance. 
One can make a rather complete 
mathematical description of the res-
piratory chain system, if that is 
necessary and useful. Then one can 
calculate a number of constants, 
such as the apparent Km for 0, ; 
extrapolate the data to infinite con-
centrations of 0 ., substrate, ADP 
and inorganic phosphate; and 
finally come out with a limiting 
value for P0 2 near the mitochon-
dria. I have done my homework on 
this and the calculated, "corrected" 
curves are shown as broken lines 
in Figure 11. In this way I obtained 
values of approximately 0.5 mm 
Hg (l,uM0 2) for 50 % inhibition 
and 5 mm Hg (9,uMO.) for a 10% 
loss in 0 2 uptake. However, the 
numbers have little meaning except 
as upper limits. Any time the rate 
of 0 2 uptake is not maximal, these 
minimal levels will be considerably 
lower; in the case of nearly starved 
yeast, perhaps 25 times. 
The figures above are for condi-
tions in which the respiratory chain 
is the only limiting factor. How-
ever, as I said, that is hardly ever 
the case. Usually the system is 
limited either by the rate of oxi-
dative phosphorylation or by the 
substrate supply. This is difficult to 
distinguish. It turns out that the rest-
ing metabolism of most cells-at 
least the ones that we have looked 
at-is not limited by a lack of ADP 
only. During resting respiration 
they do not have fully reduced 
levels of mitochondrial NAD such 
as isolated mitochondria have. 
There is also a subtle but very 
effective control of the substrate 
level. In resting metabolism the 
substrates are not present in excess. 
So there must be at least one other 
control step, but most likely there 
are several. We do not really know 
where they are located except that 
they are not in the respiratory 
chain. This type of control operates 
only in the intact cell, not in iso-
lated mitochondria. In all tissues 
that we have studied there is this 
very definite limit of substrate pro-
vision. This limitation is overcome 
immediately upon initiation of 
more active oxygen uptake. In 
other words, there is a multi-
pronged control system of overall 
oxidative metabolism. Physiological 
activity produces an increase in 
oxygen uptake and oxidative phos-
phorylation by an increase in ADP, 
but at the same time it spurs sub-
strate provision. It certainly can do 
so by increased glycolysis. This re-
sults in an increased availability of 
pyruvate for the citric acid cycle. 
Apparently there are similar con-
trols in the other pathways feeding 
into the Krebs cycle. Of course, 
there is an absolute necessity for 
meeting the increased needs. Hap-
pily, in an experiment it is often 
possible to get around this problem 
by increasing the substrates from 
the outside. 
Dr. Patterson: Could you define for 
some of us the K m02? 
Dr. Jobsis: My apologies. The 
shorthand stands for the Michaelis 
constant for oxygen. 
Let me define it very pragmati-
cally. If one does a plot of the rate 
of oxygen uptake as a function of 
the P02, one comes up, as I showed 
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with a curve which looks something 
like those in Figure 10. It is useful 
to talk about that level of oxygen 
where the rate is 50% of the maxi-
mal rate. It is often referred to as 
the apparent Km. When I was quot-
ing numbers for the Kmo2, I was 
talking about the more theoretical 
system, i.e., when one would 
have provided all conditions so that 
only the respiratory chain was limit-
ing. The higher the rate of 0 2 up-
take in the experiment, the closer 
one is approaching the true Km-
the real point of reference for the 
300 
200 
respiratory chain as an enzyme sys-
tem. 
Question: Is this the Michaelis for-
mulation applied to your system? 
Dr. Jobsis: Yes, but, of course, it 
is only a pragmatic constant. A 
midpoint or 50 % point is 
usually better defined than a "per-
ceptible decrease." Therefore, I 
often like to use the experimental, 
the apparent Km0 2• 
Question: Wouldn't it be a P02, 
then, corresponding to that 5 µ.M? 
Dr. Jobsis: No. The K m number is 
0.5 mm Hg or lµ.MO,. One can 
--t 
--2 2 ___ --=----
----=-------=r---
-- ----/.,...,.-----~ 
0 
~IOO-t-+-""7'~~-;,-"=~-------------
8 
0-t------,----.-----r----...-------.---~ 
0 2 4 6 8 10 
Fig. 11- The rate of oxygen consumption as a function of 0 2 concentration for 
ascites tumor cells (curve 1, 37°C), liver cells (curve 2, 40°C), and isolated 
liver mitochondria (curve 3, 20°C). The maximal rate observed experimentally 
(solid lines) is given the value 100. The upper curves (dashed lines) were calcu-
lated after extrapolation of the experimental data in the hypoxic range to infinite 
0 2 concentration by a Lineweaver-Burk plot. The lines on the right-hand margin 
indicate the theoretically achievable maximal rate unlimited by the supply of 
reducing equivalents. (Reprinted with permission from Handbook of Physiology, 
JObsis, 1964.) 
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use about 10 times that level as a 
lower limit for p lentiful 0 2, i.e., 5 
mm Hg or about 9µ,M. That is an 
average for 10% decrease in O, 
uptake rate, as shown in Figure 11. 
I'm not very interested in that num-
ber, however, because it's a non-
physiological one. It is calculated 
for the system when the respiratory 
chain is the only limiting situation, 
and that is hardly ever the case, if 
ever. 
Question: Micromoles per what? 
Dr. Jobsis: Micromolar-i.e. , mi-
cromoles per liter of fluid . 
Studies on Animals 
In the physiological case the 
number of interest is, of course, the 
one for that undefined condition 
when substrate is partially limiting. 
We would have to make some 
really awful generalizations to de-
fine it. In addition we would have 
to tackle the job of calculating the 
PO, midway between capillaries 
from blood flow and blood content 
data. There are too many badly 
known parameters to inspire real 
confidence. Instead we can use the 
experimental approach that is made 
possible by our ability to determine 
the adequacy of the P02 by observ-
ing the respiratory chain directly. 
We will find that PO, in the in-
spired air at which we first see 
NAD going reduced. 
What Chance and his co-workers 
did was to combine a double-beam 
reflection spectrophotometer with 
a fluorometer, both of them looking 
at the same spot on the cerebral 
cortex (Chance, Schoener and 
Schindler, 1964). The spectropho-
tometer shows the changes in the 
color of the hemoglobin as it goes 
from the oxygenated to the dis-
oxygenated form, and the fluorom-
eter gives a measure of the ade-
quacy of the oxygen for the 
respiratory chain . What is really be-
ing measured in this tissue is the 
behavior of the source, which is 
hemoglobin, in relation to that of 
the sink, which is the respiratory 
chain. In addition, we would like to 
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have something physically located 
in between-myoglobin might be 
just right-but the brain does not 
contain that, of course. 
In the experiment an animal is 
respired on different gas mixtures. 
This is the independent variable 
and is given on the ordinate of 
Figure 12. It is , of course, a much 
different scale of PO;, than in the 
previous figure . Starting out at 150 
mm Hg, we find a situation where 
we have certain values of the cur-
rents of the photomultipliers associ-
ated with the normal tissue. The 
difference between these and the 
currents recorded when the animal 
is completely anoxic, we give the 
value of 100 for both the spectro-
photometer and the fluorometer. 
These values are set out on the or-
dinate. Now we let the animal re-
spire on a mixture low in 0 ,, and 
we will look at the hemoglobin to 
see how much of it is in the oxy-
genated form and at the NADH to 
see if it goes up, i.e., shows signs of 
hypoxia. For each gas mixture you 
get two points: an average tissue 
PO, from the hemoglobin and an in-
dex of the adequacy of 0 , provision 
to the mitochondria from the flu-
orescence. At about 40 mm Hg in-
spired, the method did not see 
anything but disoxygenated hemo-
globin. Actually that means less 
than about 10% oxygenated Hb, 
because that is the level of con-
fidence of these measurements. At 
the same time the fluorometer re-
corded that the level of fluores-
cence had gone up only 35 % . In 
other words, most of the cells were 
not yet anoxic. A further decrease 
in the inspired PO, finally resulted 
in complete anoxia as defined by a 
stable, high intensity of fluores-
cence. 
Before we decide upon a limiting 
PO, value, we should discuss one 
other property of the chain . It con-
cerns the interpretation of the in-
creased NADH level in terms of 
effects of O, lack, and it arises from 
some kinetic considerations. The 
real O, sink is, of course, reduced 
cytochrome aa, because that is the 
one that reacts with oxygen. It 
turns out, again from mitochondrial 
experiments in cuvettes, that when 
one follows the rate of oxygen up-
take as a function of the PO, one 
will notice many members of the 
chain at a more reduced level be-
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Fig. 12-Blood oxygenation level and NADH fluorescence in the intact cerebral 
cortex of the rat. Abscissa: PO, of inspired gas; ordinate: change in the signals 
as a percentage of the total change produced by complete anoxia. (Reprinted 
with permission from Handbook of Physiology, JObsis, 1964, adapted from Oxy-
gen in the animal organism, Chance et al., 1964.) 
fore a measurable change in the 
rate of oxygen uptake occurs. The 
reason is a perfectly straightfor-
ward one, arising from chemical 
kinetics. Since reduced aa reacts 
with oxygen, the reaction rate is 
proportional to the reduced aa con-
centration times the O, concentra-
tion. Under conditions of plentiful 
0 2 , cytochrome a, is only 1 % re-
duced or less. There is, therefore, 
an enormous capacity for cushion-
ing the effect of low P02 on the 
reaction rate. All that is needed is 
an increased level of reduced aa. 
This is what occurs automatically 
when o. starts getting scarce, since 
it will take longer before a reduced 
a, molecule and an o. molecule will 
collide. Over the range of hypoxia 
the reduction of a3 is reflected fur-
ther and further down the chain by 
increased levels of reduction of the 
other components. The last one to 
be affected significantly will be 
NAD. Roughly speaking one can 
use a value of a measurably in-
creased NADH level (10 % ) as an 
end point. Here the cell reaches the 
detrimental range of hypoxia. 
Question: This is an intracellular 
oxygen tension? 
Dr. Jobsis: No. In Figure 12 we are 
speaking of the P02 in the gas 
mixtures. The numbers on the ordi-
nate are oxygen tensions in the 
respired air. Practically speaking 
this is, of course, the crucial num-
ber. From another point of view, 
however, we might want to know 
the average P00 in the tissue at 
which 10% reduction of NAD 
occurs in brain mitochondria. This 
turns out to be, again, about 5 
mm Hg; in this respect the brain 
mitochondria are not greatly dif-
ferent from other mitochondria. 
However, this number is of limited 
value only. The tissue level of O. 
varies, of course, depending on the 
distance from capillaries. This is the 
best we can say at the moment. 
It is also possible to approxi-
mate from the oxygen dissociation 
curve of rat hemoglobin the aver-
age capillary PO,. When N AD re-
duction due to hypoxia is about 
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10% complete, the spectrophoto-
metric signal shows that hemo-
globin is still 20% in the oxygen-
ated form. Assuming for the brain 
tissue an average venous P02 mid-
way between arterial and venous 
blood (i.e., 70 mm during the air-
breathing part of the experiment), 
then 1/ 5 the difference in signal 
between that level and the anoxic 
one gives us, from the 0 2 satura-
tion curve for rat hemoglobin, a 
PO. of 25 mm Hg. This is again a 
gross average, this time between 
venous and arterial fractions. Per-
haps the only usable numbers will 
come out of fluorometric experi-
ments such as those shown in Fig-
ure 12, with or without the differ-
ential spectrophotometer trace. 
Limitations of Fluorometric Method 
I believe that these, then, are the 
results and the present state of the 
art. There are a number of limita-
tions to the method as it stands at 
the moment. The main one is a 
limitation in resolving power. We 
are limited by the penetration of the 
excitation light into the tissue. So, 
at the moment there is not much 
sense in decreasing the lateral di-
mensions, i.e., decreasing the di-
ameter of the optical field. The 
problem is that fluorescence from 
a depth of a millimeter still con-
tributes to the signal. That is, of 
course, terribly much. One possi-
bility is the use of a different line 
of the mercury arc, say, the 330 
mµ. line. In that region there is a 
sizeable change in the depth of 
penetration of light with shorter 
wavelengths, but while 330 mµ. 
penetrates Jess deeply, it is also 
more harmful. In other words, 
there are problems, but perhaps 
they can be overcome step by step. 
This is where I want to stop. 
Discussion of this paper will be 
after the coffee break, and I would 
like to start the discussion by 
covering two slightly different 
points. 
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DISCUSSION 
Dr. Patterson: Our discussion ses-
sion now will concern this marvel-
ous and beautifully delivered ma-
terial that Dr. JObsis has given us. 
I do want to introduce a gentleman 
who has come at the suggestion of 
Dr. Doolan, our associate dean, to 
help us discuss some material that 
is so basic and so difficult for a 
number of us: Dr. Lutz Kiesow, 
who is head of the division of mo-
lecular energetics at the Naval Med-
ical Research Institute. I think Dr. 
fobsis would like to show two slides 
before the quizzing begins. 
Dr. Jobsis: Thank you for indulging 
me once more. I would like to 
bring up two more things, and since 
they are a little distant from the 
previous focus, I thought it would 
be best to wait until after the coffee 
break. 
I have looked at the fluorescence 
of the cerebral cortex from a func-
tional point of view, trying to relate 
physiological activity with levels of 
fluorescence. The activity I have 
studied is paroxysmal firing induced 
by strychnine or Metrazol. The ex-
perimental system was the cat with 
an exposed cerebral cortex, elec-
trodes on the pia mater and micro-
scopic observation of fluorescence. 
With this arrangement it is possible 
to show that a decrease in fluores-
cence accompanies each burst of 
epileptiform activity. A consider-
able amount of instrumental devel-
opment has shown that this is not 
an artefact caused by increased 
blood vessel diameter. Monitoring 
of that, as well as the administra-
tion of 10% C02, which maximizes 
vessel diameter even in rest, has 
shown the reliability of this obser-
vation. 
These results show that it is pos-
sible to distinguish between less ac-
tive and more active physiological 
conditions by the relative intensity 
of the fluorescence, i.e., the relative 
intensity of the metabolism. Jn 
terms of the scheme of Chance 
and Williams (Table 3), the extra 
physiological activity tends to force 
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the respiratory chain further away 
from the resting level (state 4) to 
the active level (state 3). The fact 
that it is possible to show this in 
the intact tissue is the first point I 
wanted to make. 
The second point concerns, per-
haps, a minor issue that can be set-
tled with the fluorescence method . 
For quite a while it has been known 
that epileptiform discharges are ac-
companied by increased metabolism 
and an expansion of the cerebral 
vascular bed. Because of this knowl-
edge it has been speculated that the 
end of a paroxysmal burst of high 
voltage EEG activity might well be 
brought about by the occurrence of 
anoxia in the cortex. This I am now 
able to deny. Under normal respira-
tory conditions, oxidations are in-
variably noted without a trace of a 
tendency toward the increased fluo-
rescence that is characteristic of 
anoxia or hypoxia. It is possible to 
produce signs of hypoxia during an 
attack, but either very low gas mix-
tures must be administered during 
the experiment or a very low rate 
of artificial respiration must be 
maintained. In addition, under such 
conditions signs of hypoxia may 
occur during an epileptiform burst 
without much effect on the further 
progress of the burst. Apparently 
the discharges can continue for 
some time without the need of con-
tinuous oxidative restoration of the 
,.._, P energy stores required for re-
couping the loss of ions. 
Dr. Worsham: Are we to under-
stand that the length of these epi-
sodes would be the same as without 
anoxia? Have you terminated the 
episode by the anoxia? 
Dr. Jobsis: Your understanding is 
correct; the burst is not terminated 
by anoxia . 
Dr. Patterson: Is your burst the 
equivalent of a convulsive seizure? 
Dr. Jobsis: Right. Usually they are 
produced by strychnine and Metra-
zol together. It is a horrible mix-
ture, but it's very effective. 
Dr. Patterson: The floor is open for 
quizzing. I think we'd like to hear 
from the members of our panel 
first. 
Dr. Kiesow: I think what has to be 
done here is to correct a few things . 
First of all , there is your extremely 
modest presentation of your con-
tribution to a rather important field 
of modern cell physiology. You 
mentioned Britton Chance and his 
almost 20-year-old efforts of analyz-
ing and characterizing the cellular 
respiratory chain and its elements. 
But I think your contributions are 
almost as, important as his, since 
you made the step back to the phys-
iological system. You freed yourself 
from this dangling sword of Damo-
cles of being a mitochondriac, and 
you went back to as intact and as 
physiological a system as you 
could find . In this context I would 
like to ask a question or two. One 
has to realize, of course, that the 
mitochondriac working with either 
mitochondria, or even subunits 
thereof, quite often has the advan-
tage of less interferences caused by 
cell constituents such as substrates, 
coenzymes and enzymes. These are 
present in intact cells but are fre-
quently absent in mitochondria and 
their subunits. The question, there-
fore, concerns your studies on the 
fluorescence of either tissue in situ 
or of muscle when excited with 
light of a wavelength of 340 or 366 
m,u. To what extent does this fluo-
rescence really reflect changes of the 
NADH concentration alone, and 
to what extent does it reflect changes 
of total of intracellular pyridine 
nucleotides--NADPH as well as 
NADH? I would also be interested 
in data which would break down 
the intracellular pyridine nucleo-
tides of your biological materials 
into the NAD and the NADP sys-
tem. Furthermore, as you subdivide 
the total, what are the ratios of the 
reduced over the oxidized forms of 
both systems? 
Dr. Jobsis: This is such an invita-
tion to expand! Dr. Kiesow has put 
his finger right on a very sore spot. 
I've thought a lot about it and done 
some experiments. I can gladly give 
some answers, although I'm sure 
they will not be as complete as he 
would like to have them. This is a 
very important point, and I did not 
go into it only because one has to 
limit a lecture in some way. 
Next to NAD (nicotinamide ade-
nine dinucleotide) there is NADP 
(nicotinamide adenine dinucleotide 
phosphate), which is the same 
molecule with an extra phosphate 
on the ribose of the adenosine. This 
is also contained within the mito-
chondria, and when it is reduced, it 
has very much the same absorption 
and fluorescence properties as 
NADH. It is also involved in cer-
tain mitochondrial reactions. This 
is not the only possible source 
of confusion, since, in addition to 
mitochondrial NAD and NADP, 
there is NAD, which is not in the 
mitochondria but in the cytoplasm. 
It is involved in glycolytic metabo-
lism, which is, of course, highly ac-
tive. I am sure this will be brought 
up later on. Finally, there is an-
other fraction of NAD in the mito-
chrondria which is, as far as we 
know at the moment, not too di-
rectly in equilibrium with the chain. 
It is not reduced directly by sub-
strates but by a so-called reversed 
flow of electrons. For this reducing 
equivalents flow in the opposite di-
rection, as usual; that means uphill 
in an energy diagram. This costs 
energy, of course, and high-energy 
phosphates or high-energy inter-
mediates are needed to do this. I 
don't want to go too far into it. It 
does not add to the present discus-
sion. I just wanted to bring it up 
to show that the picture is complex. 
Let us go from the easier part 
of the question to the more difficult. 
The NAD in the cytoplasm is gly-
colytically active. This fraction does 
not interchange freely with that 
which is in the mitochondria. In 
fact, NADH added to isolated mito-
chondria will not be oxidized. There 
is a separate pathway for intercom-
munication of reducing equivalents, 
but it doesn't concern us here be-
cause the problem is: Since it is 
NADH and becomes alternately 
oxidized and reduced, how do you 
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know that you're not partially meas-
uring it? The only indications I 
have are some studies on muscle, 
excised muscle, where we looked 
very hard for possible cytoplasmic 
effects in the presence and absence 
of iodoacetate. There was no con-
tribution that we could see. This 
appears puzzling, because the con-
centrations are very similar. Happily 
for us, the fact is that NADH has 
a tremendously increased fluores.-
cence efficiency when in mitochon-
dria. It fluoresces. up to 20 times 
more intensely per concentration 
unit than it does in solution or, 
apparently, in the cytoplasm. This 
is the reason why our signal is de-
rived, as far as I can see, from 
mitochondrial NADH. 
NADPH is a different problem. 
It is involved in various other bio-
chemical steps, and it is also oxi-
dizable and reducible and should 
contribute absolutely the same type 
of signal. There are two points that 
save the day. First, there happens 
to be very little NADP present 
compared to NAD. Second, both 
Dr. Chance and I, independently-
Dr. Chance for liver and I for brain 
-have analyzed biochemically for 
NADP. In my case, the experi-
ments were closely related to the 
fluorescence experiments. We meas-
ured the fluorescence in one spot. 
We produced a maximal decrease 
in fluorescence with strychnine ad-
ministered i. v. and took a sample 
from the other hemisphere. In other 
words, in the middle of a strychnine 
attack we froze a piece of tissue 
and removed it. Next we let the 
brain go fully anoxic by apnea and 
took a second sample right in and 
around the point of optical obser-
vation. Then we analyzed with en-
zymatic methods and compared 
left side against right side, anoxic 
against oxidized. It turns out that 
the NADPH concentration doesn't 
change in such an experiment, 
while the NADH does and, in-
cidentally, shows a good correlation 
with the increase in fluorescence. 
So, we're pretty sure that NADPH 
does not interfere. Dr. Chance has 
been able to pick up some signs of 
an effect in the liver but with slow 
kinetics. In other words, he has 
seen NADPH changes, but they 
were at a different rate than the 
fluorescence and the NADH 
changes. 
In conclusion, then , we appear 
to be rather safe. However, there 
remains the cytoplasmic fraction of 
NADH. We cannot analyze for it 
differentially. It is probably also 
affected by some of the same 
factors that affect electron transport. 
The only reassurance is the fact 
that , in various other preparations 
such as muscle, it has been shown 
that its quantum efficiency of fluo-
rescence is some 10 to 20 times less 
than that of NADH associated with 
the oxidative phosphorylation func-
tion of the respiratory chain .. That 
is the answer, I think. 
Dr. Kiesow: You were referring to 
the problem of energy-linked re-
versal of the electron transport. If 
I remember correctly, Chance re-
cently published a paper where he 
demonstrates that this step is af-
fected by hyperbaric oxygen. He 
claims that this effect is not due to 
an increased rate of autoxidation 
of reduced flavoprotein , but is due 
to a direct effect of hyperbaric 
oxygen on this reversal of the elec-
tron transfer. What would you con-
sider to be hyperbaric conditions 
here; hyperbaric in regard to oxy-
gen, that is? 
Dr. Jobsis: If you want a hard 
number, I'm sure I cannot give it 
to you. I think anything that pro-
duces a level higher than about 
30 to 40 mm Hg-averaged tissue 
P02 is probably hyperbaric. That's 
the range for which you need a 
hyperbaric chamber. But I'm not 
too well acquainted with hyperbaric 
work. The experiment that you 
refer to was the following. When 
mitochondria are exposed to high 
oxygen pressure (5 to 12 atmos-
pheres) it appears that one inhibits, 
the reduction of the N AD fraction 
which receives its reducing equiva-
lents by reversed electron flow (the 
pathway that goes from succinate 
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via fiavoproteins to NAD). Ex-
posure to hyperbaric oxygen pre-
vents NAD reduction upon the 
addition of succinate. This is sug-
gestively linked to some measure-
ments of Sanders, Woodhall and 
their group in which they have 
shown that very high levels of suc-
cinate in the blood protect against 
cerebral damage by hyperbaric oxy-
gen. (A. P. Sanders, I. H. Hall, 
P. J. Cavanaugh and B. Woodhall. 
In Proceedings 3rd International 
Conference on Hyperbaric Medi-
cine. I. W. Brown, Jr. and B .. G . 
Cox (eds.). Nat. Acad. Sci.-Nat. 
Res. Council, Publ. No. 1404, pp. 
73-82, 1966). The suggestive im-
plication is that a tremendous 
amount of succinate-and these are 
really enormous levels they are 
working with-produces a protec-
tive effect by partially overcoming 
this inhibition. However, I don't 
believe that Chance has been able 
to verify this by direct observation. 
Until now, regardless of the dose 
of administered succinate, he just 
hasn't seen it. 
Dr. Robin: Dr. JObsis, I would like 
to join my colleagues in thanking 
you for this superb discussion, and 
I won't end that compliment by 
using a harpoon. I should like to 
ask you a question. It's a self-serv-
ing one, because after you answer 
it, I would like to make a comment, 
regardless of how you answer the 
question. I think that one of the 
purposes of a conference like this 
is to highlight matters that are of 
potentially great interest for the 
future in the areas that are being 
discussed. The question that I 
would like to ask is : Are there data 
available concerning whether the 
peroxidase pathways, the non-cyto-
chrome pathways involving energy 
generation, are linked, on one hand, 
with ATP generation and, on the 
other hand, with acetyl Co-A as 
an intermediary? In other words, 
how closely are they linked to the 
usual kind of oxidative phosphoryl-
ation? 
Dr. Ji:ibsis: Well, I'm very glad that 
you gave me a choice of any 
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answer, because I am not too well 
acquainted with these systems. I 
have looked into this matter a bit, 
since I worried that these reactions 
might affect the mitochondrial re-
action. Being a rather pragmatic ex-
perimentalist, I immediately stopped 
going into further details when I 
found that they did not seem to 
hinder my system of measurement. 
Hence, I would really like to hear 
your comments. 
Dr. Robin: What I should like to 
indicate is that the area of non-
cytochrome-linked energy genera-
tion is, in my opinion, a potentially 
very important one and that there 
are at least two physiological cir-
cumstances that I know of in which 
the possibility of non-cytochrome-
linked energy generation has been 
raised. With your permission, Dr. 
JObsis, I might indicate these. 
One system is the alveolar macro-
phage, which is being extensively 
investigated by a number of 
workers, including my colleague, 
Dr. Bernard Gee. This fits in with 
this type of audience, because there 
are lung types and heart types, and 
one of the important functions of 
the alveolar macrophage, of course, 
is to phagocytize inert, dead bacteria, 
and living bacteria. Almost certainly 
this is an endergonic, an energy-re-
quiring process, and one can estab-
lish this by several lines of evidence, 
but one of the most striking lines 
of evidence is that, if you measure 
the oxygen consumption of the 
alveolar macrophage in its resting 
state and then let it gobble up dead 
bacteria, there is a brisk increase 
in oxygen consumption .. Now, if 
you manipulate this system by par-
tially inhibiting cytochrome b by 
using antimycin, or you use cyanide 
and partially inhibit aa so that the 
cells are still living, there is obvi-
ously a profound decrease in oxy-
gen consumption, but there is no 
effect on phagocytosis. There is evi-
dence which indicates that, although 
the general level of oxygen con-
sumption is decreased in these cells, 
there is still, at this reduced oxygen 
consumption, an increase under 
circumstances of phagocytosis. Ob-
viously, the easiest way to recon-
cile these data would be to say that 
there must be another energy link, 
another oxygen-requiring process, 
which does not involve the respira-
tory chain. 
The second system is the nu-
cleated red cell of the shark, and 
the findings to be discussed are 
probably characteristic of most nu-
cleated red cells. Unlike mammalian 
red cells, nucleated red cells are 
brisk oxygen consumers. One can 
measure oxygen consumption in 
these cells by standard methods. 
One of the important energy-re-
quiring processes in red cells gen-
erally is the process by which 
sodium is transported from the in-
side of the red cell to the plasma 
against an electrochemical gradi-
ent. If one is interested in ener-
getics, one is, of course, anxious to 
quantitate the metabolic costs of 
performing this transport work. 
(Dr. Ji:ibsis's colleague, Dr. Toste-
son has spent a good part of his 
professional life in this area.) Now, 
if you take this cell and inhibit an-
aerobic glycolysis by using one of 
the standard inhibitors, there will 
be a marked decrease in sodium 
transport. So, presumably, the 
major energy source for this trans-
port process is anaerobic glycolysis. 
If you take large doses of cyanide 
and you inhibit the respiratory 
chain, you get no change in trans-
port. This raises an important 
question, because presumably both 
respiratory chain activity and an-
aerobic glycolysis result in ATP gen-
eration. How can the cell distin-
guish between the ATP which is 
being generated oxidatively, which 
is not available for transport, and 
the ATP that is being generated by 
anaerobic glycolysis? Even more in-
teresting than this is the finding 
that exposure of cells to nitrogen 
leads to a decrease in transport 
rate. I can summarize these results 
as follows. Let us assume the nor-
mal sodium transport rate is 15 
mEq Na+/kg red cell H.O per hour, 
transported from the inside of the 
red cell to the outside. If one stops 
anaerobic glycolysis, the transport 
rate falls to 5 mEq Na•/kg red cell 
H.O. If one cuts out the respiratory 
transport chain by either antimycin 
or cyanide, the transport rate re-
mains at 15 mEq Na•/kg red cell 
H.O. On the other hand, if one de-
creases oxygen availablity by ex-
posing the cells to 100% nitrogen, 
the transport rate falls to, say, 8 
mEq Na•/kg red cell H.O. This 
suggests that some aliquot of energy 
cost for this process is being medi-
ated by non-cytochrome oxygen 
consumption, and the sum total of 
this is, then , as I said at the begin-
ning, that non-cytochrome-medi-
ated energy generation is probably 
a much more important field than 
has been appreciated in the past 
and may be a "hot" area of work 
in the future . Would you comment 
on this? 
Dr. Jobsis: I am very glad to hear 
these data. For the last half year 
a graduate student, Mr. Hersey, and 
I have been looking for these kinds 
of systems. I guess we will just have 
to go to the Caribbean and catch a 
shark or two. 
I would like to point out one 
thing. Earlier in my presentation I 
talked about autoxidative flavo-
proteins, and I mentioned that there 
is no known energy-saving step. 
High energy phosphate is definitely 
not being formed. This could really 
say something else again, namely 
that energy utilization, although not 
mediated by ATP, might perhaps 
be a direct function of the mem-
brane components without the in-
tervention of ATP. It is a most 
important point. Altogether, I'm 
very glad indeed that this gives us 
a good excuse to go to the Car-
ibbean around Christmas. 
Dr. Carter: I have just three short 
questions: 1) Does the fluorescence 
generation result in any significant 
temperature change of the tissue? 
2) Have you thought of the possi-
bility of using a fiber optic to come 
beneath to limit your depth? We've 
had some success in using fiber op-
tics in kidney, in other words, pok-
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ing in and coming up. It sounds a 
little drastic, but remember that 
these penetrations are very small, 
and it's conceivable that you would 
have a known depth of un-damaged 
kidney and brain under these cir-
cumstances. And finally, 3) Could 
fluorescence possibly be used as a 
measurement of blood flow? I 
should certainly like to hear a little 
more about why fluorescence is 
related to blood flow. Specifically, 
we would be very much interested 
in measuring blood flow on the 
surface of the kidney. 
Dr. Patterson: If I remember cor-
rectly, you actually said you cor-
rected the fluorescence for changes 
in blood flow, and I was fascinated 
by the possibility that this tech-
nique might be used to measure 
blood flow. 
Dr. Jobsis: I didn't measure it; I 
just got rid of it. 
Your first point, Dr. Carter, was 
about the temperature. We have a 
highly filtered light beam. Prac-
tically all infrared is eliminated. In 
addition, we have measured the 
temperature by using a small therm-
istor, enclosing it in a drop of saline 
and putting that on top of the cor-
tex. The rate of heating is insignifi-
cant as long as the blood supply is 
intact. This carries heat away very 
effectively. However, if you stop 
the circulation, in a dead cat, for 
example, you have a slight rise in 
temperature; but there is greater 
danger in direct radiation damage 
of the tissue. We don't know the 
mechanism, but it is signified by 
pinprick hematomas appearing in 
the optical field. This is much worse 
for the shorter wavelengths. The 
366 mµ, line is a good compromise 
between effectiveness of NADH ex-
citation and relative lack of damage. 
The second point was about the 
fiber optics. First of all, I didn't 
know one could go down to that 
small dimension. I'd love to talk 
instrumentation with you for a 
while after the meeting. This cer-
tainly sounds very exciting. There 
is a problem which I'm sure will 
be solved in the near future, and 
that is that the last time I looked 
into fiber optics, the index of refrac-
tion of available materials was such 
that the wavelengths of light be-
tween 300 and 400 mµ, were not 
transmitted well by the fiber optics. 
I'm sure that something can be 
done about it. I'm not sure that I'm 
the right person to try to do it , 
though. 
Comment from audience: There 
are plastic ones now available. 
Dr. Jobsis: They are very bad at the 
moment, because plastics have some 
absorption in that region. For small 
thicknesses it is no problem. In fact , 
all my cuvettes and muscle cham-
bers are made of lucite, but they 
are limited to about a millimeter 
of thickness in the light path. If 
you're going through fiber optics, 
however, you are working with cen-
timeters. 
Comment from Audience: But 
you've got too much light, anyway, 
you said. 
Dr. Jobsis: Well, that's relative. An 
additional problem is a faint blue 
fluorescence excited by 366 m µ,. 
Now, the final point about blood 
flow. This was very much a head-
ache, especially changes of blood 
content in the field. Hemoglobin 
will diminish the fluorescence in 
two ways. First, it will absorb ex-
citation light, and then it will ab-
sorb the emitted fluorescent light. 
When light penetrates a red cell , 
practically all the 366 mµ, light is 
absorbed, and almost the same 
occurs for the fluorescence. There-
fore, the problem that you face is 
the following. You are looking 
down on an optical field on the 
surface of the tissue. Through the 
field run capillaries, venules, and 
arterioles. By eye, it looks very 
much like a network of black 
threads running through a blue 
background. Lateral and depth 
resolution are not sufficient to avoid 
anything but the very largest ves-
sels. When something increases the 
metabolic activity, blood flow in-
creases either by an opening up of 
more capillaries or by distention of 
vessels. The effective field from 
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which you are recording decreases, 
therefore, every time you have an 
increased distention of the vessels. 
Excitation light is scattered in 
the tissue, and some of it is picked 
up by the objective. This fraction is 
affected by changes in blood volume 
in much the same way as the 
fluorescence . With appropriate op-
tical beam-splitters and filters, it 
can be measured and provides a 
control for the light absorption 
changes affecting the fluorescence. 
I have often wondered whether 
these changes in the scattered 366 
mµ, light might not provide the 
basis for a useful means of monitor-
ing blood flow parameters. 
Dr. Patterson: You are actually not 
correcting the change of blood 
flow, but the changes in blood 
volume. 
Dr. Jobsis: Correct. 
Dr. Worsham: It is really farther 
removed than that. What you are 
really correcting is the amount of 
hemoglobin in the field. 
Dr. Jobsis: Yes. You see more 
hemoglobin in the field due to dis-
tention of the vessels. Incidentally, 
the response time is quite good. 
The time resolution is in the neigh-
borhood of two seconds. 
Dr. Patterson: We would now like 
to throw this program open to 
general questioning of our distin-
guished speakers. 
Dr. Huf: I have two questions. 
The first one is related to the prob-
lem which the first discussant raised 
about the importance of specific 
factors located outside of the mito-
chondria. I am now raising the 
question of the importance of un-
specific factors. Take the muscle, 
for instance. When you throw the 
muscle into activity, you are bound 
to get all kinds of unspecific 
changes, membrane changes, pro-
tein contraction, pH changes, os-
motic changes. Hence, you don't 
really look at a specific system, let's 
say the B system, in the same physi-
cochemical environment. To what 
extent do unspecific factors, the 
kind mentioned, affect at least the 
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transient changes and, perhaps, 
steady-state changes as well? 
The second question deals with 
the point which you made about 
the significance of the rate at which 
metabolites enter into cells. 'Vhen 
you come into the region of very 
low oxygen tension, would it be 
useful to consider as a limiting 
factor the rate of oxygen supply? 
You do have a high oxygen dif-
fusion coefficient, but you have re-
duced the oxygen gradient to prac-
tically nothing; so it comes, as it 
were, to a competition between 
limiting factors. You may have a 
high concentration of substrate of 
low mobility, or you may have 
a low concentration of oxygen 
which bas a high diffusion coeffi-
cient. So, what is limiting? 
Dr. Jobsis: Let us start with the 
second question first. We are pretty 
sure that oxygen is limiting at very 
low P02 levels; say, less than 0.5 
mm Hg. Above that there is a large 
region in which we can not decide 
what the limiting factor is. With 
tissues, and especially tissue slices, 
it probably would be the low P02 
due to diffusion path lengths. There 
is no telling when this is the case 
unless you do an experiment with 
varying P02 levels. The uncertainty 
about the diffusion is, of course, 
part of all considerations of this 
nature. Fortunately, most cell mem-
branes do not exclude either 0 2 or 
C02, so no significant new barriers 
are erected. 
There is one aspect of the con-
trol of a sequence of reactions that 
escapes the uninitiated. I think Dr. 
Worsham has some very significant 
things to say about this. The prob-
lem is that most of our kinetic 
thinking is derived from enzymes 
in a cuvette or a test-tube. We can 
throw a substrate in and measure 
how fast it is converted. %en you 
have added an insufficient amount 
of substrate and you see a de-
crease in the rate, you know im-
mediately and quite correctly that 
your substrate concentration has 
limited the velocity. However, in a 
mitochondrial system and even 
much more so in cells, there is a 
very complex situation with many 
control points. Take, for instance, 
the glycolytic chain. There is 
usually plenty of glycogen, yet 
lactate formation does not pro-
ceed maximally. Here there may be 
as many as six different control 
points. In the mitochondrial system 
itself there are three already in 
oxidative phosphorylation. There is 
not one primary control point; each 
one of the sites of oxidative phos-
phorylation provides control, and 
the rate becomes different if you 
take just one away. There is, there-
fore, a very complex interaction, 
complex enough to boggle the mind 
really. One needs to use computers 
to represent all the individual rates 
and their influences on each other. 
However, at very low oxygen levels, 
I think it is. warranted to say oxy-
gen is limiting and, of course, in a 
tissue, oxygen diffusion is one of 
the limiting factors. 
As to your first point, yes, there 
is a tremendous amount of difficulty 
with non-specific changes. Just 
from an instrumental point of view, 
it is difficult, because when a mus-
cle contracts, it scatters light quite 
differently than when it is in the 
resting condition. The double-beam 
method is necessary to overcome 
this. For a first approximation this 
is all right. However, light of dif-
ferent wavelengths is not scattered 
equally. Low wavelengths are scat-
tered more intensely than high 
wavelengths. %en your expected 
absorption is very small , this will 
get in the way. Then you must use 
two reference wavelengths, strad-
dling the wavelength that you want 
to measure. In other words, if I 
want to measure 550 m 1.t, I use as 
reference 540 and 560 mµ,, thereby 
getting rid of most of the wave-
length specific effect. However, the 
increase in scatter is not linear with 
the wavelength; it is a power func-
tion, and one has to correct also 
for that. 
Dr. Worsham: It depends on the 
direction of scattering, too, unless 
you have a spherical molecule. 
Dr. JObsis: That doesn't bother us 
too much, because that effect is 
not too wavelength specific. It's a 
very correct point, but pragmati-
cally we don't worry about it much. 
Now, your final point. There are 
not only instrumental difficulties, 
but physiochemically a contracted 
muscle is a different system. We can 
only rely at this point on changes 
we can observe in mitochondria in 
cuvettes and compare them to those 
in the tissue. It turns out that we 
don't get too many differences by 
changing any extracellular param-
eters. The functions we are study-
ing are rather insensititive to pH. 
Only large pH changes show any-
thing, and I have some data on 
changes in intracellular pH relevant 
to this. 
Dr. Huf: What are large changes of 
pH? 
Dr. JObsis: .2 of pH unit, or some-
thing close to that. 
Dr. Huf: How much does the pH 
change when the muscle contracts? 
Dr. JObsis: I have looked at the 
pH changes after small amounts of 
contractile activity and before gly-
colysis is stimulated. During gly-
colysis really large changes occur in 
the internal pH. But keeping away 
from lactic acid formation as best 
you can, pH changes occur as a 
result of a single twitch, which are 
in the neighborhood of .05 pH 
unit. Other people have looked at 
this long ago and found the same. 
Then there may be osmotic 
changes. They are very unpleasant 
when they are large. It looks, how-
ever, as if that does not occur in 
the muscle cell, with the possible 
exception of some increased os-
motic pressure due to long term 
anoxia. In general, we have covered 
the difficulties pragmatically, but we 
certainly have not stopped trying 
to study each for its own worth. 
Question from the Audience: At 
what level of hypoxia does this 
reaction of strychnine disappear 
completely? 
Dr. Jobsis: You mean an increased 
EEG? I have not tried that. The 
spontaneous EEG disappears some-
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where in the neighborhood of 
breathing 3 % to 5% oxygen, at 
least in our blissfully anesthetized 
animals. I really don't know at what 
level of PO;, the paroxysmal, strych-
nine-induced EEG stops. 
Dr. Kontos: I was wondering whe-
ther your method is fast enough to 
observe any rapid spontaneous 
changes in living muscle, for in-
stance, in response to changes in 
blood flow. The records you have 
shown before you interfered with 
some particular intervention looked 
pretty close to straight lines. Is this 
true? 
Dr. JObsis: These muscle records 
were from excised muscle, so we 
avoided that problem. Dr. Stainsby, 
Dr. Renkin and I have planned to 
investigate that a bit later this fall. 
Dr. Renkin is specifically interested 
because of possible changes in capil-
lary distribution, distribution of 
open and closed capillaries. Dr. 
Stainsby is interested in the rela-
tion between lactate production 
during exercise and possible hy-
poxia in muscles doing different 
kinds of work. I am just interested. 
Dr. Worsham: I want to make a 
comment, if I may, but first I want 
to ask a question. I'd like to ask 
how well we know the characteris-
tics of each step along this cyto-
chrome chain. Do we know the 
rate constants and the Michaelis 
enzyme constants all the way along 
for each step? 
Dr. Jobsis: We do not know 
enough, but we know approxi-
mately. You can observe each com-
ponent of the respiratory chain with 
the exception of cytochrome c,. 
Many of the rate constants are 
well determined, although one al-
ways wishes for better. 
Dr. Worsham: I'd like to suggest 
that perhaps the time has come for 
you to join forces with the theorists, 
if you classify yourself as a prag-
matist, and go ahead and try to 
simulate your system from the 
known in vi tro characteristics of 
these various steps. The best thing 
you could hope for is that your 
computer simulation, a model built 
up from the known isolated char-
acteristics, would then agree with 
what you see in some of your ex-
periments. I am impressed with how 
well you have cut out a lot of 
complications. This is always the 
place to begin for a good theoreti-
cal approach; in fact, you think like 
a theorist and work like an experi-
mentalist, but you have done the 
best experimental job of getting a 
real simple system to study. Per-
haps you have a chance now of 
building a model, putting it on to a 
fairly modest computer and trying 
to see if your model does agree with 
what you have observed. One needs 
theory to program an analog com-
puter to simulate the reactions that 
occur in a metabolic pathway. Dr. 
JObsis has well indicated the nature 
of the problem. He wiggles the 
oxygen concentration at one end of 
the chain, and he wants to know 
what happens to the NADH rate 
turnover at the other end of the 
chain. This problem is not easy to 
solve. 
Dr. Patterson: Well, you are teach-
ing kinetics of reversible processes, 
and a lot of these are irreversible. 
Dr. Worsham: That's not true. The 
difference is that the metabolic sys-
tems in the animals we have studied 
have no beginning. That's really the 
difference. There's no C. in the 
processes that you study. There's a 
steady state you can think of, a 
metabolic steady state; you perturb 
this, and it goes to another steady 
state. What I'm saying is that the 
kinetics you think of as pot kinetics 
are quite different from the kinetics 
of steady-state metabolic path rates 
to additional steady states. 
Dr. Kiesow: I completely agree that 
the problem here is the flow kinetics 
-rather the pot kinetics-and I 
was just wondering, since it ob-
viously is a question of measuring 
the intracellular oxygen concentra-
tion with an indicator as close as 
possible to oxygen, whether you 
have ever tossed around the thought 
of using the photodissociation of 
the carbon monoxide complex of a3 
as an indicator for intracellular 
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oxygen? The second question: Al-
though the autoxidation contributes 
to only 10% of the total oxygen 
consumption, it should have, and 
it does have, the characteristic of 
being much more proportional to 
the partial pressure of oxygen than 
this a,, which is very low saturation 
pressure. Isn't it possible, perhaps, 
also to use the state of the redox 
system at the level of flavoprotein 
as an indicator for intracellular 
oxygen pressure based on the au-
toxidation where the rest of the 
chain is hooked off by either an 
inhibitor, antimycin A, or cyanide 
or carbon monoxide? 
Dr. Jobsis: Actually I'd like to go 
in reverse order, which is not too 
pleasant, but I don't think that 
would be an insurmountable prob-
lem. From the specific to the more 
general, I have never thought of 
using the autoxidative fiavopro-
teins as indicators. However, it 
sounds like a very, very good sug-
gestion indeed if we can be sure we 
have blocked the other fiavopro-
teins. We need cyanide. That can 
be solved. A bit of difficulty lies in 
trying to get an index to fiavopro-
teins. They have rather weakly dif-
ferentiated spectra. However, a col-
league of all of us in this field, Dr. 
Jose Ramirez of Mexico City, who 
unfortunately died in a car ac-
cident, had, at the time of his death, 
completed a system of fluorescence 
measurements of fiavoprotein that 
he thought was very promising. I 
am sorry to say that progress on 
this ceased with his death .. 
As for the remark of Dr. Wor-
sham, I really wanted him to come 
up with this very important point 
that we are not working in the 
same type of chemical kinetics as 
that so often found in textbooks. 
Dr. Worsham: You mean they 
taught you the wrong thing? 
Dr. Jobsis: Yes, for this purpose it 
is wrong. Recently, however, the 
physical chemists have been get-
ting more interested in such sys-
tems. I am glad that they are cor-
recting themselves. I should be 
more humble at this point, because 
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I am a rank amateur in computer 
work, but I love to play around 
with computers and sometimes have 
to tear myself away from the analog 
because it's so wonderfully neat. 
You put in the values, the curves 
come out beautifully, and you 
think, "Now I'm doing science!" 
Of course, you're not doing science 
at all, because a dirty experiment is 
really what science is made of. To 
interpret a dirty experiment, how-
ever, you need an analog computer. 
Although I've done a bit of this 
sort of work, this is being done very 
intensively at the Johnson Founda-
tion by a whole group of computer 
people. In fact, they have made a 
system, starting out with glucose 
and some other substrates in gly-
colysis, taking in the whole res-
piratory chain and taking ATP con-
sumer reactions into account, also. 
Dr. Worsham: Have you tried their 
model to simulate your experi-
ments? 
Dr. Jobsis: No. I, myself, have not 
played with the analog computer in 
this system. I have played with it 
in the interpretation of energy turn-
over in muscle contraction. 
Dr. Worsham: Why don't you go 
to their computer and say, "Let 
me ... 
Dr. Jobsis: Well, they are doing 
this, so I am just waiting for them 
to do it. Of course, sometimes they 
don't ask the right questions. 
Dr. Worsham: That's where they 
need you. 
Dr. Jobsis: Yes, but you'll have to 
convince them of that. There are 
two fe llows, each with his own 
group; one working with an analog 
computer group, the other with a 
digital computer group. By the way, 
I think they have purposely been 
put next to each other to produce 
some healthy competition. 
Dr. Worsham: By the way, your 
comment was excellent. Thomas 
Huxley said, "The great tragedy of 
modern science is the slaying of a 
beautiful theory by an ugly fact." 
Dr. Robin: Two comments. Dr. 
JObsis, maybe this afternoon I can 
provide you with an animal in 
which you can completely knock 
out a, and have both the animal 
and the brain survive for at least 
one to two weeks. Secondly, since 
we're being philosophical and com-
paring the differences between how 
things work in a complicated cell 
and a complicated animal, macro-
molecules and ions being put in 
a test-tube with some water and 
shaken up together, I think the 
problem is even deeper than that. 
We have no c.. In many kinetic 
processes the kinetic changes that 
take place depend on the previous 
point along the curve, and, there-
fore, if we are describing any of 
these multicomplicated steps, we 
have to describe them each in terms 
of a family, at best. Consequently, 
I am not sure you've been teaching 
the wrong kind of physical chem-
istry. I am not sure that the right 
kind of physical chemistry yet 
exists which can accurately define 
these kinds of systems, and, there-
fore, what we try to do is try to 
make the best approximation we 
can with the method and thinking 
that is available until, hopefully, 
somebody comes along with a 
physical-chemical-theoretical struc-
ture which can deal with variables 
which change so rapidly. 
Dr. Patterson: Haven't people like 
Dr. Prigogine, working with ther-
modynamics of irreversible pro-
cesses, and others studying the irre-
versible processes helped somewhat 
in this area? 
Dr. Robin: Yes, although I think 
you are referring to something that 
is a little bit different. The differ-
ence between reversible and ir-
reversible thermodynamics is in-
volved in your question. The basic 
assumption that is made in classi-
cal thermodynamics is that you deal 
with equilibria, and, of course, in 
living systems there are no equilib-
ria. The consequences of not hav-
ing equilibria are that the best you 
can deal with are steady states or 
quasi-steady states, and the gen-
eral equations that apply to each of 
these two different approaches are 
quite different. 
